IndraLab

Statements

USP35 decreases the amount of (E)-4-hydroxynon-2-enal. 1 / 1

| 1

reach

"Furthermore, immunohistochemistry analysis revealed that USP35 increased the levels of SLC7A11, whereas (+)-JQ-1 treatment significantly reduced the levels of SLC7A11, and increased the level of 4-HNE, a marker of ferroptosis, in ER+ breast tumors (Fig. 7F, G)."

39820080

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP35 decreases the amount of (E)-4-hydroxynon-2-enal. 1 / 1

INDRA sources:

Databases

Reading